Nonetheless, senescent dysfunctional β-cells from insulin resistant mouse models and T1D models (NOD mice) are capable of changing their phenotype into functional and mature upon the exposure to senolytic drugs. This evidence concerns the gene INS and type 1 diabetes mellitus.